Juhani K.E. Airaksinen, MD, PhD, FESC

Pooled Analysis of Trials Comparing Titanium-Nitride-Oxide-Coated Stents with Paclitaxel-Eluting Stents in Patients Undergoing

Coronary stents have reduced the risk of periprocedural complications and restenosis compared to balloon angioplasty alone.1,2 In spite of this progress, restenosis is still a clinical problem of bare metal stents, particularly in certain...

Coronary stents have reduced the...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

07/06/2010

Fausto Biancari , MD, PhD;

Lorentz Raeber , MD;

Michael Billinger , MD;

Gender-Based Analysis of the 3-Year Outcome of Bioactive Stents Versus Paclitaxel-Eluting Stents in Patients with Acute Myocardial Infarction: An Insight from the TITAX-AMI Trial

Otto M. Hess , MD, PhD;

ABSTRACT: We performed a pooled analysis of three trials comparing titanium-nitride-oxide-coated bioactive stents (BAS) with paclitaxel-eluting stents (PES) in 1,774 patients. All patients were followed for 12 months. The primary outcomes...

ABSTRACT: We performed a...

07/06/2010

Journal of Invasive Cardiology

Original Contribution

02/29/2012

Matti Niemela , MD, PhD;

Kari Kervinen , MD, PhD;

Mikko Pietila , MD, PhD;

Jussi Sia , MD;

Kai Nyman , MD;

Wail Nammas , MD, PhD;

Early Vascular Healing After Endothelial Progenitor Cell Capturing Stent Implantation

Petri O. Tuomainen , MD, PhD;

Abstract: Background. The TITAX-AMI trial demonstrated a better clinical outcome of titanium-nitride-oxide-coated bioactive stents (BAS) as compared with paclitaxel-eluting stents (PES) in patients with acute myocardial infarction (MI)...

Abstract: Background. The...

02/29/2012

Journal of Invasive Cardiology

Original Contribution

11/29/2012

Tuomas O. Kiviniemi , MD, PhD;

Tuomas Lehtinen , MD;

Jussi Mikkelsson , MD, PhD;